Anastasia Stamoulou
Anastasia is a Health Economics and HTA Analyst at IQVIA. She specialises in projects related to HTA and joint clinical assessment submissions, with a focus on HTA strategy and dossier preparation across different therapeutic areas.
ArticleOvercoming barriers to oncology combination therapies in the UK and EU
Colleagues at IQVIA discuss ways to expedite positive HTA outcomes for innovative combination therapies, alleviating the bottlenecks inherent in the current system.